![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Clinical Trials
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2...
Drug Research
Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus
Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory...
News
Merck to acquire Themis for SARS-CoV-2 vaccine
Merck announced on May 26 that it has entered an agreement to acquire privately held Themis, a company that is developing a vaccine candidate...
Clinical Trials
Glenmark to Combine Two Anti-Viral Drugs; Start Trials on Indian COVID-19 Patients
Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and...
Press Releases
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19
AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership with Takara Bio. The companies will partner in...
Press Releases
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic
Exyte, world-renowned for the design and construction of high tech facilities, and Univercells Technologies, a provider of novel biomanufacturing technologies for economic and scalable...
Packaging & Labelling
FedEx Delivers Relief Shipment to U.S. in fight against COVID-19
Amid the global COVID-19 pandemic, FedEx Express, a subsidiary of FedEx Corp. and the world’s largest express transportation company, has been working with nonprofit...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read